These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3544769)

  • 1. Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism.
    Nikkilä EA; Taskinen MR; Sane T
    Am Heart J; 1987 Feb; 113(2 Pt 2):543-8. PubMed ID: 3544769
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nicotinic acid therapy on high-density lipoprotein metabolism in type II and type IV hyperlipoproteinaemia.
    Packard CJ; Stewart JM; Third JL; Morgan HG; Lawrie TD; Shepherd J
    Biochim Biophys Acta; 1980 Apr; 618(1):53-62. PubMed ID: 6990991
    [No Abstract]   [Full Text] [Related]  

  • 4. The transport of triglyceride in the high-density lipoproteins of human plasma.
    Barter PJ; Connor WE
    J Lab Clin Med; 1975 Feb; 85(2):260-72. PubMed ID: 163284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of high density lipoprotein apolipoprotein CII in triglyceride metabolism.
    Kashyap ML; Srivastava LS; Hynd BA; Perisutti G; Brady DW; Gartside P; Glueck CJ
    Lipids; 1978 Dec; 13(12):933-42. PubMed ID: 220489
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.
    Shepherd J; Packard CJ; Patsch JR; Gotto AM; Taunton OD
    J Clin Invest; 1979 May; 63(5):858-67. PubMed ID: 221531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins.
    Alaupovic P
    Can J Biochem; 1981 Aug; 59(8):565-79. PubMed ID: 7028220
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipoprotein metabolism].
    Corvilain B
    Rev Med Brux; 1997 Feb; 18(1):3-9. PubMed ID: 9132915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified approach to lipoprotein kinetics and factors affecting serum cholesterol and triglyceride concentrations.
    Hopkins PN; Williams RR
    Am J Clin Nutr; 1981 Nov; 34(11):2560-90. PubMed ID: 7030050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease.
    Schaefer EJ; Blum CB; Levy RI; Jenkins LL; Alaupovic P; Foster DM; Brewer HB
    N Engl J Med; 1978 Oct; 299(17):905-10. PubMed ID: 211412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 13. Marked overproduction of low density lipoprotein apolipoprotein B in a subject with heterozygous familial hypercholesterolemia. Effect of portacaval shunting.
    Ginsberg H; Davidson N; Le NA; Gibson J; Ahrens EH; Brown WV
    Biochim Biophys Acta; 1982 Aug; 712(2):250-7. PubMed ID: 7126604
    [No Abstract]   [Full Text] [Related]  

  • 14. [Apolipoproteins - an important diagnostic indicator in the evaluation of coronary disease risk].
    Naruszewicz M; Nowicka G
    Pol Arch Med Wewn; 1980 Aug; 64(2):161-6. PubMed ID: 7433154
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females.
    Schaefer EJ; Foster DM; Zech LA; Lindgren FT; Brewer HB; Levy RI
    J Clin Endocrinol Metab; 1983 Aug; 57(2):262-7. PubMed ID: 6408108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipoproteins, apolipoproteins and intravenous fat tolerance in young athletes.
    Ericsson M; Johnson O; Tollin C; Furberg B; Backman C; Angquist K
    Scand J Rehabil Med; 1982; 14(4):209-12. PubMed ID: 7178868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the pathogenesis of lipoprotein disorders.
    Kashyap ML
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):73-6. PubMed ID: 7344605
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoprotein fractions and receptors: a role for probucol?
    Bilheimer DW
    Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
    Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
    Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.